Floatz logo

wt-1 analog peptide vaccine

Malignant Mesothelioma

Memorial Sloan Kettering Cancer CentervaccinePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

29 Active assets in the Malignant Mesothelioma cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Dr Jean Yannis PERENTES
Phase 2BB
Inno-206
Mayo Clinic
Phase 2BB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 2BB
Sargramostim
Memorial Sloan Kettering Cancer Center
Phase 2BB
L-Alanosine
Memorial Sloan Kettering Cancer Center
Phase 2B

View all 50 →

Same molecule, other indications

wt-1 analog peptide vaccine is also rated in:

primary peritoneal carcinomaDormant
CC
Indicative ·
46 / 100
View asset →
leukemiaDormant
CC
Indicative ·
40 / 100
View asset →
lung cancerDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →